Inovio Pharmaceuticals Statistics
Total Valuation
BMV:INO has a market cap or net worth of MXN 1.53 billion. The enterprise value is 453.38 million.
Market Cap | 1.53B |
Enterprise Value | 453.38M |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 36.67M |
Shares Outstanding | n/a |
Shares Change (YoY) | +37.06% |
Shares Change (QoQ) | +28.74% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 33.08M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 265.08 |
PB Ratio | 1.46 |
P/TBV Ratio | 1.46 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.23 |
EV / Sales | 84.63 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -0.22 |
Financial Position
The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.22.
Current Ratio | 2.63 |
Quick Ratio | 2.55 |
Debt / Equity | 0.22 |
Debt / EBITDA | n/a |
Debt / FCF | -0.11 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -132.44% and return on invested capital (ROIC) is -77.74%.
Return on Equity (ROE) | -132.44% |
Return on Assets (ROA) | -61.21% |
Return on Invested Capital (ROIC) | -77.74% |
Return on Capital Employed (ROCE) | -176.77% |
Revenue Per Employee | 43,181 |
Profits Per Employee | -14.72M |
Employee Count | 134 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.10% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -73.10% |
50-Day Moving Average | 37.51 |
200-Day Moving Average | 62.83 |
Relative Strength Index (RSI) | 67.08 |
Average Volume (20 Days) | 150 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 10.40 |
Income Statement
In the last 12 months, BMV:INO had revenue of MXN 5.79 million and -1.97 billion in losses. Loss per share was -63.63.
Revenue | 5.79M |
Gross Profit | -1.44B |
Operating Income | -2.17B |
Pretax Income | -1.97B |
Net Income | -1.97B |
EBITDA | -2.13B |
EBIT | -2.17B |
Loss Per Share | -63.63 |
Balance Sheet
The company has 1.40 billion in cash and 230.37 million in debt, giving a net cash position of 1.17 billion.
Cash & Cash Equivalents | 1.40B |
Total Debt | 230.37M |
Net Cash | 1.17B |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.05B |
Book Value Per Share | 28.56 |
Working Capital | 910.91M |
Cash Flow
In the last 12 months, operating cash flow was -2.09 billion and capital expenditures -10.46 million, giving a free cash flow of -2.10 billion.
Operating Cash Flow | -2.09B |
Capital Expenditures | -10.46M |
Free Cash Flow | -2.10B |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | -37,430.19% |
Pretax Margin | -34,079.58% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
BMV:INO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -37.06% |
Shareholder Yield | n/a |
Earnings Yield | -128.56% |
FCF Yield | -136.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 0.0833333333.
Last Split Date | Jan 25, 2024 |
Split Type | Reverse |
Split Ratio | 0.0833333333 |
Scores
BMV:INO has an Altman Z-Score of -28.64. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -28.64 |
Piotroski F-Score | n/a |